Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-21
2007-08-21
Page, Thurman K. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S260100
Reexamination Certificate
active
10312767
ABSTRACT:
The present invention relates to 2-aminomethylthieno[2,3-d]pyrimidines of the general formula (I)in which the radicals R1to R6have the meaning indicated in the text. The compounds show phosphodiesterase V inhibition and can be employed for the treatment of conditions of the cardiovascular system and for the treatment of potency disorders.
REFERENCES:
patent: 6110920 (2000-08-01), Rochus et al.
patent: 6130223 (2000-10-01), Janas et al.
patent: 8777419 (2004-08-01), Rochus et al.
patent: 6787548 (2004-09-01), Jonas et al.
patent: 2003/0022906 (2003-01-01), Brandle et al.
patent: 2004/0029900 (2004-02-01), Jonas et al.
patent: 2004/0044011 (2004-03-01), Jonas et al.
patent: WO94/28902 (1994-12-01), None
Takase et al., J.Med.Chem, 36, p. 3765+ (1993).
Takase et al., J.Med.Chem, 37, p. 2106+ (1994).
Beier Norbert
Christadler Maria
Jonas Rochus
Schelling Pierre
Lao MLouisa
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Page Thurman K.
LandOfFree
2-Aminoalkyl-thieno[2,3-d]pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-Aminoalkyl-thieno[2,3-d]pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Aminoalkyl-thieno[2,3-d]pyrimidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3888318